nodes	percent_of_prediction	percent_of_DWPC	metapath
Triamcinolone—PTGS2—melanoma	0.56	1	CbGaD
Triamcinolone—CYP3A4—Temozolomide—melanoma	0.0692	0.576	CbGbCtD
Triamcinolone—CYP3A4—Vemurafenib—melanoma	0.0379	0.316	CbGbCtD
Triamcinolone—CYP3A4—Docetaxel—melanoma	0.013	0.108	CbGbCtD
Triamcinolone—Monoplegia—Carmustine—melanoma	0.00976	0.0427	CcSEcCtD
Triamcinolone—Hyperadrenocorticism—Temozolomide—melanoma	0.00943	0.0413	CcSEcCtD
Triamcinolone—Cushing's syndrome—Carmustine—melanoma	0.00665	0.0291	CcSEcCtD
Triamcinolone—Localized exfoliation—Bleomycin—melanoma	0.00642	0.0281	CcSEcCtD
Triamcinolone—Skin striae—Bleomycin—melanoma	0.00544	0.0238	CcSEcCtD
Triamcinolone—Folliculitis—Vemurafenib—melanoma	0.00454	0.0199	CcSEcCtD
Triamcinolone—Meningitis—Carmustine—melanoma	0.00389	0.017	CcSEcCtD
Triamcinolone—Trauma—Bleomycin—melanoma	0.00363	0.0159	CcSEcCtD
Triamcinolone—Intracranial pressure increased—Carmustine—melanoma	0.00361	0.0158	CcSEcCtD
Triamcinolone—Impaired healing—Carmustine—melanoma	0.00349	0.0153	CcSEcCtD
Triamcinolone—Vasculitis—Vemurafenib—melanoma	0.00292	0.0128	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Bleomycin—melanoma	0.00291	0.0127	CcSEcCtD
Triamcinolone—Lupus erythematosus—Docetaxel—melanoma	0.0026	0.0114	CcSEcCtD
Triamcinolone—Folliculitis—Dactinomycin—melanoma	0.00257	0.0112	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Carmustine—melanoma	0.00254	0.0111	CcSEcCtD
Triamcinolone—Hepatomegaly—Dactinomycin—melanoma	0.00228	0.00997	CcSEcCtD
Triamcinolone—Embolism—Temozolomide—melanoma	0.00227	0.00995	CcSEcCtD
Triamcinolone—Tooth disorder—Temozolomide—melanoma	0.00225	0.00984	CcSEcCtD
Triamcinolone—Myopathy—Temozolomide—melanoma	0.00208	0.0091	CcSEcCtD
Triamcinolone—Abscess—Carmustine—melanoma	0.00191	0.00835	CcSEcCtD
Triamcinolone—Ulcer—Bleomycin—melanoma	0.00183	0.008	CcSEcCtD
Triamcinolone—Petechiae—Temozolomide—melanoma	0.00177	0.00776	CcSEcCtD
Triamcinolone—Menstruation irregular—Docetaxel—melanoma	0.00175	0.00767	CcSEcCtD
Triamcinolone—Systemic lupus erythematosus—Docetaxel—melanoma	0.00175	0.00767	CcSEcCtD
Triamcinolone—Ulcer—Dactinomycin—melanoma	0.0017	0.00746	CcSEcCtD
Triamcinolone—Wheezing—Bleomycin—melanoma	0.00168	0.00735	CcSEcCtD
Triamcinolone—Skin exfoliation—Bleomycin—melanoma	0.00165	0.00723	CcSEcCtD
Triamcinolone—Skin hyperpigmentation—Docetaxel—melanoma	0.00163	0.00714	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Vemurafenib—melanoma	0.00156	0.00685	CcSEcCtD
Triamcinolone—Embolism—Docetaxel—melanoma	0.00151	0.00661	CcSEcCtD
Triamcinolone—Candida infection—Carmustine—melanoma	0.00144	0.00631	CcSEcCtD
Triamcinolone—Skin exfoliation—Carmustine—melanoma	0.00144	0.00631	CcSEcCtD
Triamcinolone—Neuropathy—Carmustine—melanoma	0.00142	0.0062	CcSEcCtD
Triamcinolone—Candida infection—Temozolomide—melanoma	0.00139	0.0061	CcSEcCtD
Triamcinolone—Skin exfoliation—Temozolomide—melanoma	0.00139	0.0061	CcSEcCtD
Triamcinolone—Neuropathy—Temozolomide—melanoma	0.00137	0.00599	CcSEcCtD
Triamcinolone—Injury—Bleomycin—melanoma	0.00137	0.00598	CcSEcCtD
Triamcinolone—Throat sore—Docetaxel—melanoma	0.00135	0.00589	CcSEcCtD
Triamcinolone—Oropharyngeal discomfort—Docetaxel—melanoma	0.00133	0.00584	CcSEcCtD
Triamcinolone—Dermatitis atopic—Docetaxel—melanoma	0.00131	0.00574	CcSEcCtD
Triamcinolone—Neuritis—Docetaxel—melanoma	0.0013	0.00569	CcSEcCtD
Triamcinolone—Thrombophlebitis—Carmustine—melanoma	0.00127	0.00554	CcSEcCtD
Triamcinolone—Diabetes mellitus—Carmustine—melanoma	0.00126	0.00551	CcSEcCtD
Triamcinolone—Erythema—Vemurafenib—melanoma	0.00125	0.00546	CcSEcCtD
Triamcinolone—Thrombophlebitis—Temozolomide—melanoma	0.00122	0.00535	CcSEcCtD
Triamcinolone—Dysgeusia—Vemurafenib—melanoma	0.00122	0.00535	CcSEcCtD
Triamcinolone—Back pain—Vemurafenib—melanoma	0.00121	0.00528	CcSEcCtD
Triamcinolone—Injury—Carmustine—melanoma	0.00119	0.00522	CcSEcCtD
Triamcinolone—Vascular purpura—Temozolomide—melanoma	0.00118	0.00518	CcSEcCtD
Triamcinolone—PTGS2—leg—melanoma	0.00117	0.142	CbGeAlD
Triamcinolone—Purpura—Temozolomide—melanoma	0.0011	0.00481	CcSEcCtD
Triamcinolone—Cough—Vemurafenib—melanoma	0.00109	0.00477	CcSEcCtD
Triamcinolone—Oropharyngeal pain—Docetaxel—melanoma	0.00107	0.00467	CcSEcCtD
Triamcinolone—Myalgia—Vemurafenib—melanoma	0.00106	0.00465	CcSEcCtD
Triamcinolone—PTGS2—hindlimb—melanoma	0.00105	0.127	CbGeAlD
Triamcinolone—Affect lability—Temozolomide—melanoma	0.00104	0.00456	CcSEcCtD
Triamcinolone—Anaphylactic shock—Vemurafenib—melanoma	0.00102	0.00446	CcSEcCtD
Triamcinolone—Infection—Vemurafenib—melanoma	0.00101	0.00443	CcSEcCtD
Triamcinolone—Mood swings—Temozolomide—melanoma	0.001	0.00439	CcSEcCtD
Triamcinolone—Muscular weakness—Carmustine—melanoma	0.000966	0.00423	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Bleomycin—melanoma	0.000953	0.00417	CcSEcCtD
Triamcinolone—Myocardial infarction—Bleomycin—melanoma	0.000948	0.00415	CcSEcCtD
Triamcinolone—Muscular weakness—Temozolomide—melanoma	0.000934	0.00409	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Vemurafenib—melanoma	0.000927	0.00406	CcSEcCtD
Triamcinolone—Candida infection—Docetaxel—melanoma	0.000926	0.00405	CcSEcCtD
Triamcinolone—Skin exfoliation—Docetaxel—melanoma	0.000926	0.00405	CcSEcCtD
Triamcinolone—Abdominal distension—Temozolomide—melanoma	0.000921	0.00403	CcSEcCtD
Triamcinolone—Fluid retention—Docetaxel—melanoma	0.000921	0.00403	CcSEcCtD
Triamcinolone—Neuropathy—Docetaxel—melanoma	0.00091	0.00399	CcSEcCtD
Triamcinolone—PTGS2—appendage—melanoma	0.000897	0.109	CbGeAlD
Triamcinolone—Sweating increased—Temozolomide—melanoma	0.000891	0.0039	CcSEcCtD
Triamcinolone—Bronchitis—Temozolomide—melanoma	0.00088	0.00385	CcSEcCtD
Triamcinolone—Fatigue—Vemurafenib—melanoma	0.000878	0.00384	CcSEcCtD
Triamcinolone—Haemoglobin—Bleomycin—melanoma	0.000873	0.00382	CcSEcCtD
Triamcinolone—Haemorrhage—Bleomycin—melanoma	0.000868	0.0038	CcSEcCtD
Triamcinolone—Pulmonary oedema—Docetaxel—melanoma	0.000863	0.00378	CcSEcCtD
Triamcinolone—Upper respiratory tract infection—Temozolomide—melanoma	0.00085	0.00372	CcSEcCtD
Triamcinolone—Weight increased—Temozolomide—melanoma	0.000833	0.00365	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Carmustine—melanoma	0.000827	0.00362	CcSEcCtD
Triamcinolone—Thrombophlebitis—Docetaxel—melanoma	0.000813	0.00356	CcSEcCtD
Triamcinolone—Body temperature increased—Vemurafenib—melanoma	0.000805	0.00352	CcSEcCtD
Triamcinolone—Pharyngitis—Dactinomycin—melanoma	0.000804	0.00352	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Temozolomide—melanoma	0.0008	0.0035	CcSEcCtD
Triamcinolone—Cardiac failure congestive—Docetaxel—melanoma	0.000776	0.0034	CcSEcCtD
Triamcinolone—Haemoglobin—Carmustine—melanoma	0.000762	0.00333	CcSEcCtD
Triamcinolone—Haemorrhage—Carmustine—melanoma	0.000758	0.00332	CcSEcCtD
Triamcinolone—Erythema—Bleomycin—melanoma	0.000756	0.00331	CcSEcCtD
Triamcinolone—Hypersensitivity—Vemurafenib—melanoma	0.00075	0.00328	CcSEcCtD
Triamcinolone—PTGS2—skin epidermis—melanoma	0.000746	0.0908	CbGeAlD
Triamcinolone—Dermatitis bullous—Docetaxel—melanoma	0.000737	0.00323	CcSEcCtD
Triamcinolone—Haemoglobin—Temozolomide—melanoma	0.000736	0.00322	CcSEcCtD
Triamcinolone—Haemorrhage—Temozolomide—melanoma	0.000732	0.00321	CcSEcCtD
Triamcinolone—Asthenia—Vemurafenib—melanoma	0.00073	0.0032	CcSEcCtD
Triamcinolone—Pharyngitis—Temozolomide—melanoma	0.000727	0.00318	CcSEcCtD
Triamcinolone—Pruritus—Vemurafenib—melanoma	0.00072	0.00315	CcSEcCtD
Triamcinolone—Erythema—Dactinomycin—melanoma	0.000705	0.00309	CcSEcCtD
Triamcinolone—Ill-defined disorder—Bleomycin—melanoma	0.000701	0.00307	CcSEcCtD
Triamcinolone—Malaise—Bleomycin—melanoma	0.000681	0.00298	CcSEcCtD
Triamcinolone—Arrhythmia—Carmustine—melanoma	0.000677	0.00296	CcSEcCtD
Triamcinolone—Dizziness—Vemurafenib—melanoma	0.000673	0.00295	CcSEcCtD
Triamcinolone—Erythema—Carmustine—melanoma	0.00066	0.00289	CcSEcCtD
Triamcinolone—Cough—Bleomycin—melanoma	0.000659	0.00289	CcSEcCtD
Triamcinolone—Ill-defined disorder—Dactinomycin—melanoma	0.000654	0.00286	CcSEcCtD
Triamcinolone—Vomiting—Vemurafenib—melanoma	0.000647	0.00283	CcSEcCtD
Triamcinolone—Myalgia—Bleomycin—melanoma	0.000643	0.00282	CcSEcCtD
Triamcinolone—Rash—Vemurafenib—melanoma	0.000642	0.00281	CcSEcCtD
Triamcinolone—Dermatitis—Vemurafenib—melanoma	0.000641	0.00281	CcSEcCtD
Triamcinolone—Back pain—Carmustine—melanoma	0.000638	0.00279	CcSEcCtD
Triamcinolone—Headache—Vemurafenib—melanoma	0.000638	0.00279	CcSEcCtD
Triamcinolone—Erythema—Temozolomide—melanoma	0.000637	0.00279	CcSEcCtD
Triamcinolone—Discomfort—Bleomycin—melanoma	0.000636	0.00278	CcSEcCtD
Triamcinolone—Malaise—Dactinomycin—melanoma	0.000636	0.00278	CcSEcCtD
Triamcinolone—Dysgeusia—Temozolomide—melanoma	0.000624	0.00273	CcSEcCtD
Triamcinolone—Oedema—Bleomycin—melanoma	0.000617	0.0027	CcSEcCtD
Triamcinolone—Anaphylactic shock—Bleomycin—melanoma	0.000617	0.0027	CcSEcCtD
Triamcinolone—Back pain—Temozolomide—melanoma	0.000617	0.0027	CcSEcCtD
Triamcinolone—Infection—Bleomycin—melanoma	0.000613	0.00268	CcSEcCtD
Triamcinolone—Nausea—Vemurafenib—melanoma	0.000605	0.00265	CcSEcCtD
Triamcinolone—Myalgia—Dactinomycin—melanoma	0.0006	0.00263	CcSEcCtD
Triamcinolone—Discomfort—Dactinomycin—melanoma	0.000593	0.0026	CcSEcCtD
Triamcinolone—Ill-defined disorder—Temozolomide—melanoma	0.000591	0.00259	CcSEcCtD
Triamcinolone—Angioedema—Temozolomide—melanoma	0.000582	0.00255	CcSEcCtD
Triamcinolone—Oedema—Dactinomycin—melanoma	0.000575	0.00252	CcSEcCtD
Triamcinolone—Malaise—Temozolomide—melanoma	0.000575	0.00252	CcSEcCtD
Triamcinolone—Vertigo—Temozolomide—melanoma	0.000573	0.00251	CcSEcCtD
Triamcinolone—Convulsion—Carmustine—melanoma	0.000572	0.0025	CcSEcCtD
Triamcinolone—Infection—Dactinomycin—melanoma	0.000571	0.0025	CcSEcCtD
Triamcinolone—Hypertension—Carmustine—melanoma	0.00057	0.00249	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Bleomycin—melanoma	0.000562	0.00246	CcSEcCtD
Triamcinolone—Myalgia—Carmustine—melanoma	0.000562	0.00246	CcSEcCtD
Triamcinolone—Cough—Temozolomide—melanoma	0.000556	0.00244	CcSEcCtD
Triamcinolone—Paraesthesia—Bleomycin—melanoma	0.000554	0.00242	CcSEcCtD
Triamcinolone—Weight increased—Docetaxel—melanoma	0.000554	0.00242	CcSEcCtD
Triamcinolone—Convulsion—Temozolomide—melanoma	0.000552	0.00242	CcSEcCtD
Triamcinolone—Hypertension—Temozolomide—melanoma	0.00055	0.00241	CcSEcCtD
Triamcinolone—Dyspnoea—Bleomycin—melanoma	0.00055	0.00241	CcSEcCtD
Triamcinolone—Myalgia—Temozolomide—melanoma	0.000543	0.00238	CcSEcCtD
Triamcinolone—PTGS2—endothelium—melanoma	0.000541	0.0659	CbGeAlD
Triamcinolone—Oedema—Carmustine—melanoma	0.000538	0.00236	CcSEcCtD
Triamcinolone—Discomfort—Temozolomide—melanoma	0.000536	0.00235	CcSEcCtD
Triamcinolone—Infection—Carmustine—melanoma	0.000535	0.00234	CcSEcCtD
Triamcinolone—Acute coronary syndrome—Docetaxel—melanoma	0.000535	0.00234	CcSEcCtD
Triamcinolone—Myocardial infarction—Docetaxel—melanoma	0.000532	0.00233	CcSEcCtD
Triamcinolone—Neuropathy peripheral—Docetaxel—melanoma	0.000532	0.00233	CcSEcCtD
Triamcinolone—Dry mouth—Temozolomide—melanoma	0.000531	0.00232	CcSEcCtD
Triamcinolone—Pain—Bleomycin—melanoma	0.000527	0.00231	CcSEcCtD
Triamcinolone—Conjunctivitis—Docetaxel—melanoma	0.000527	0.00231	CcSEcCtD
Triamcinolone—Tachycardia—Carmustine—melanoma	0.000525	0.0023	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Dactinomycin—melanoma	0.000524	0.00229	CcSEcCtD
Triamcinolone—Oedema—Temozolomide—melanoma	0.00052	0.00228	CcSEcCtD
Triamcinolone—Anaphylactic shock—Temozolomide—melanoma	0.00052	0.00228	CcSEcCtD
Triamcinolone—Infection—Temozolomide—melanoma	0.000517	0.00226	CcSEcCtD
Triamcinolone—Epistaxis—Docetaxel—melanoma	0.000512	0.00224	CcSEcCtD
Triamcinolone—Feeling abnormal—Bleomycin—melanoma	0.000508	0.00223	CcSEcCtD
Triamcinolone—Hyperhidrosis—Temozolomide—melanoma	0.000503	0.0022	CcSEcCtD
Triamcinolone—PTGS2—blood vessel—melanoma	0.000499	0.0607	CbGeAlD
Triamcinolone—Fatigue—Dactinomycin—melanoma	0.000496	0.00217	CcSEcCtD
Triamcinolone—Pain—Dactinomycin—melanoma	0.000492	0.00215	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Carmustine—melanoma	0.00049	0.00215	CcSEcCtD
Triamcinolone—Urticaria—Bleomycin—melanoma	0.00049	0.00215	CcSEcCtD
Triamcinolone—Haemoglobin—Docetaxel—melanoma	0.000489	0.00214	CcSEcCtD
Triamcinolone—Rhinitis—Docetaxel—melanoma	0.000488	0.00214	CcSEcCtD
Triamcinolone—Body temperature increased—Bleomycin—melanoma	0.000488	0.00213	CcSEcCtD
Triamcinolone—Haemorrhage—Docetaxel—melanoma	0.000487	0.00213	CcSEcCtD
Triamcinolone—Insomnia—Carmustine—melanoma	0.000487	0.00213	CcSEcCtD
Triamcinolone—Paraesthesia—Carmustine—melanoma	0.000483	0.00212	CcSEcCtD
Triamcinolone—Pharyngitis—Docetaxel—melanoma	0.000483	0.00212	CcSEcCtD
Triamcinolone—Dyspnoea—Carmustine—melanoma	0.00048	0.0021	CcSEcCtD
Triamcinolone—Feeling abnormal—Dactinomycin—melanoma	0.000474	0.00208	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Temozolomide—melanoma	0.000474	0.00208	CcSEcCtD
Triamcinolone—Insomnia—Temozolomide—melanoma	0.000471	0.00206	CcSEcCtD
Triamcinolone—Paraesthesia—Temozolomide—melanoma	0.000467	0.00205	CcSEcCtD
Triamcinolone—Dyspnoea—Temozolomide—melanoma	0.000464	0.00203	CcSEcCtD
Triamcinolone—Pain—Carmustine—melanoma	0.00046	0.00202	CcSEcCtD
Triamcinolone—Dyspepsia—Temozolomide—melanoma	0.000458	0.00201	CcSEcCtD
Triamcinolone—Body temperature increased—Dactinomycin—melanoma	0.000455	0.00199	CcSEcCtD
Triamcinolone—Hypersensitivity—Bleomycin—melanoma	0.000454	0.00199	CcSEcCtD
Triamcinolone—Fatigue—Temozolomide—melanoma	0.000449	0.00196	CcSEcCtD
Triamcinolone—Pain—Temozolomide—melanoma	0.000445	0.00195	CcSEcCtD
Triamcinolone—Feeling abnormal—Carmustine—melanoma	0.000444	0.00194	CcSEcCtD
Triamcinolone—Asthenia—Bleomycin—melanoma	0.000443	0.00194	CcSEcCtD
Triamcinolone—Pruritus—Bleomycin—melanoma	0.000436	0.00191	CcSEcCtD
Triamcinolone—Arrhythmia—Docetaxel—melanoma	0.000435	0.0019	CcSEcCtD
Triamcinolone—Feeling abnormal—Temozolomide—melanoma	0.000429	0.00188	CcSEcCtD
Triamcinolone—Body temperature increased—Carmustine—melanoma	0.000426	0.00186	CcSEcCtD
Triamcinolone—Erythema—Docetaxel—melanoma	0.000424	0.00186	CcSEcCtD
Triamcinolone—Hypersensitivity—Dactinomycin—melanoma	0.000424	0.00186	CcSEcCtD
Triamcinolone—Dexamethasone—CYP17A1—melanoma	0.000422	0.161	CrCbGaD
Triamcinolone—Dysgeusia—Docetaxel—melanoma	0.000415	0.00182	CcSEcCtD
Triamcinolone—Urticaria—Temozolomide—melanoma	0.000413	0.00181	CcSEcCtD
Triamcinolone—Asthenia—Dactinomycin—melanoma	0.000413	0.00181	CcSEcCtD
Triamcinolone—NR3C1—neck—melanoma	0.000413	0.0502	CbGeAlD
Triamcinolone—Body temperature increased—Temozolomide—melanoma	0.000411	0.0018	CcSEcCtD
Triamcinolone—Back pain—Docetaxel—melanoma	0.00041	0.0018	CcSEcCtD
Triamcinolone—SERPINA6—head—melanoma	0.000398	0.0484	CbGeAlD
Triamcinolone—Hypersensitivity—Carmustine—melanoma	0.000397	0.00174	CcSEcCtD
Triamcinolone—Vomiting—Bleomycin—melanoma	0.000392	0.00172	CcSEcCtD
Triamcinolone—Rash—Bleomycin—melanoma	0.000389	0.0017	CcSEcCtD
Triamcinolone—Dermatitis—Bleomycin—melanoma	0.000389	0.0017	CcSEcCtD
Triamcinolone—Asthenia—Carmustine—melanoma	0.000386	0.00169	CcSEcCtD
Triamcinolone—Hypersensitivity—Temozolomide—melanoma	0.000383	0.00168	CcSEcCtD
Triamcinolone—Syncope—Docetaxel—melanoma	0.00038	0.00166	CcSEcCtD
Triamcinolone—Asthenia—Temozolomide—melanoma	0.000373	0.00163	CcSEcCtD
Triamcinolone—Loss of consciousness—Docetaxel—melanoma	0.000373	0.00163	CcSEcCtD
Triamcinolone—Cough—Docetaxel—melanoma	0.00037	0.00162	CcSEcCtD
Triamcinolone—Pruritus—Temozolomide—melanoma	0.000368	0.00161	CcSEcCtD
Triamcinolone—Convulsion—Docetaxel—melanoma	0.000367	0.00161	CcSEcCtD
Triamcinolone—Nausea—Bleomycin—melanoma	0.000366	0.0016	CcSEcCtD
Triamcinolone—Hypertension—Docetaxel—melanoma	0.000366	0.0016	CcSEcCtD
Triamcinolone—Vomiting—Dactinomycin—melanoma	0.000366	0.0016	CcSEcCtD
Triamcinolone—Rash—Dactinomycin—melanoma	0.000363	0.00159	CcSEcCtD
Triamcinolone—Myalgia—Docetaxel—melanoma	0.000361	0.00158	CcSEcCtD
Triamcinolone—Dizziness—Carmustine—melanoma	0.000356	0.00156	CcSEcCtD
Triamcinolone—Dry mouth—Docetaxel—melanoma	0.000353	0.00155	CcSEcCtD
Triamcinolone—Oedema—Docetaxel—melanoma	0.000346	0.00151	CcSEcCtD
Triamcinolone—Anaphylactic shock—Docetaxel—melanoma	0.000346	0.00151	CcSEcCtD
Triamcinolone—Dizziness—Temozolomide—melanoma	0.000344	0.00151	CcSEcCtD
Triamcinolone—Infection—Docetaxel—melanoma	0.000344	0.00151	CcSEcCtD
Triamcinolone—Dexamethasone—NOS2—melanoma	0.000344	0.132	CrCbGaD
Triamcinolone—Vomiting—Carmustine—melanoma	0.000342	0.0015	CcSEcCtD
Triamcinolone—Nausea—Dactinomycin—melanoma	0.000342	0.0015	CcSEcCtD
Triamcinolone—Shock—Docetaxel—melanoma	0.00034	0.00149	CcSEcCtD
Triamcinolone—Rash—Carmustine—melanoma	0.000339	0.00149	CcSEcCtD
Triamcinolone—Dermatitis—Carmustine—melanoma	0.000339	0.00148	CcSEcCtD
Triamcinolone—Tachycardia—Docetaxel—melanoma	0.000338	0.00148	CcSEcCtD
Triamcinolone—Headache—Carmustine—melanoma	0.000337	0.00148	CcSEcCtD
Triamcinolone—Vomiting—Temozolomide—melanoma	0.000331	0.00145	CcSEcCtD
Triamcinolone—Rash—Temozolomide—melanoma	0.000328	0.00144	CcSEcCtD
Triamcinolone—Dermatitis—Temozolomide—melanoma	0.000328	0.00144	CcSEcCtD
Triamcinolone—Headache—Temozolomide—melanoma	0.000326	0.00143	CcSEcCtD
Triamcinolone—Nausea—Carmustine—melanoma	0.00032	0.0014	CcSEcCtD
Triamcinolone—Musculoskeletal discomfort—Docetaxel—melanoma	0.000315	0.00138	CcSEcCtD
Triamcinolone—Insomnia—Docetaxel—melanoma	0.000313	0.00137	CcSEcCtD
Triamcinolone—Paraesthesia—Docetaxel—melanoma	0.000311	0.00136	CcSEcCtD
Triamcinolone—Nausea—Temozolomide—melanoma	0.000309	0.00135	CcSEcCtD
Triamcinolone—Dyspnoea—Docetaxel—melanoma	0.000308	0.00135	CcSEcCtD
Triamcinolone—NR3C1—eye—melanoma	0.000307	0.0373	CbGeAlD
Triamcinolone—Dyspepsia—Docetaxel—melanoma	0.000305	0.00133	CcSEcCtD
Triamcinolone—BCHE—skin of body—melanoma	0.0003	0.0365	CbGeAlD
Triamcinolone—Fatigue—Docetaxel—melanoma	0.000298	0.00131	CcSEcCtD
Triamcinolone—Pain—Docetaxel—melanoma	0.000296	0.0013	CcSEcCtD
Triamcinolone—Dexamethasone—CYP1B1—melanoma	0.000292	0.112	CrCbGaD
Triamcinolone—Feeling abnormal—Docetaxel—melanoma	0.000285	0.00125	CcSEcCtD
Triamcinolone—BCHE—mammalian vulva—melanoma	0.000274	0.0333	CbGeAlD
Triamcinolone—Body temperature increased—Docetaxel—melanoma	0.000274	0.0012	CcSEcCtD
Triamcinolone—NR3C1—skin of body—melanoma	0.000267	0.0325	CbGeAlD
Triamcinolone—Fluticasone furoate—ABCB1—melanoma	0.000262	0.1	CrCbGaD
Triamcinolone—Hypersensitivity—Docetaxel—melanoma	0.000255	0.00112	CcSEcCtD
Triamcinolone—Asthenia—Docetaxel—melanoma	0.000248	0.00109	CcSEcCtD
Triamcinolone—Pruritus—Docetaxel—melanoma	0.000245	0.00107	CcSEcCtD
Triamcinolone—NR3C1—mammalian vulva—melanoma	0.000244	0.0296	CbGeAlD
Triamcinolone—PTGS2—skin of body—melanoma	0.000231	0.0281	CbGeAlD
Triamcinolone—Dizziness—Docetaxel—melanoma	0.000229	0.001	CcSEcCtD
Triamcinolone—Vomiting—Docetaxel—melanoma	0.00022	0.000963	CcSEcCtD
Triamcinolone—Rash—Docetaxel—melanoma	0.000218	0.000955	CcSEcCtD
Triamcinolone—Dermatitis—Docetaxel—melanoma	0.000218	0.000954	CcSEcCtD
Triamcinolone—Headache—Docetaxel—melanoma	0.000217	0.000949	CcSEcCtD
Triamcinolone—Methylprednisolone—ABCB1—melanoma	0.000209	0.0799	CrCbGaD
Triamcinolone—Nausea—Docetaxel—melanoma	0.000206	0.0009	CcSEcCtD
Triamcinolone—BCHE—head—melanoma	0.000196	0.0238	CbGeAlD
Triamcinolone—NR3C1—head—melanoma	0.000174	0.0212	CbGeAlD
Triamcinolone—Betamethasone—PTGS2—melanoma	0.00017	0.0649	CrCbGaD
Triamcinolone—Prednisone—ALB—melanoma	0.000167	0.0641	CrCbGaD
Triamcinolone—Prednisone—ABCB1—melanoma	0.00016	0.0611	CrCbGaD
Triamcinolone—PTGS2—head—melanoma	0.000151	0.0183	CbGeAlD
Triamcinolone—Prednisolone—ABCB1—melanoma	0.000147	0.0563	CrCbGaD
Triamcinolone—Betamethasone—ABCB1—melanoma	0.000144	0.0552	CrCbGaD
Triamcinolone—BCHE—lymph node—melanoma	0.000137	0.0167	CbGeAlD
Triamcinolone—NR3C1—lymph node—melanoma	0.000122	0.0148	CbGeAlD
Triamcinolone—Hydrocortisone—ABCB1—melanoma	0.000113	0.0431	CrCbGaD
Triamcinolone—PTGS2—lymph node—melanoma	0.000106	0.0128	CbGeAlD
Triamcinolone—Dexamethasone—PTGS2—melanoma	9.86e-05	0.0378	CrCbGaD
Triamcinolone—Dexamethasone—ABCB1—melanoma	8.38e-05	0.0321	CrCbGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—KRAS—melanoma	6.86e-05	0.000855	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SNRPE—melanoma	6.85e-05	0.000854	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—SKI—melanoma	6.85e-05	0.000854	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MMP9—melanoma	6.84e-05	0.000853	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—TNF—melanoma	6.66e-05	0.00083	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP17A1—melanoma	6.64e-05	0.000828	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP17A1—melanoma	6.55e-05	0.000817	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PHGDH—melanoma	6.51e-05	0.000812	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—LUM—melanoma	6.51e-05	0.000812	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP8—melanoma	6.51e-05	0.000812	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—CDKN2B—melanoma	6.51e-05	0.000811	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—VEGFA—melanoma	6.49e-05	0.000809	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—TNF—melanoma	6.43e-05	0.000802	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—IGF1—melanoma	6.4e-05	0.000798	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—HPSE—melanoma	6.39e-05	0.000797	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—VDR—melanoma	6.34e-05	0.000791	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CUBN—melanoma	6.27e-05	0.000782	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAP2K1—melanoma	6.19e-05	0.000771	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CUL3—melanoma	6.18e-05	0.00077	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TRRAP—melanoma	6.18e-05	0.00077	CbGpPWpGaD
Triamcinolone—BCHE—Phospholipid metabolism—PIK3CA—melanoma	6.15e-05	0.000767	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CSPG4—melanoma	6.06e-05	0.000755	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SDHD—melanoma	6.06e-05	0.000755	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—BSG—melanoma	6.06e-05	0.000755	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKR1B10—melanoma	6.01e-05	0.000749	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—MDM2—melanoma	5.91e-05	0.000736	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—FGF2—melanoma	5.88e-05	0.000734	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GPAM—melanoma	5.87e-05	0.000731	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP17A1—melanoma	5.84e-05	0.000728	CbGpPWpGaD
Triamcinolone—PTGS2—C-MYB transcription factor network—HRAS—melanoma	5.83e-05	0.000727	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MAPK3—melanoma	5.81e-05	0.000725	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MYC—melanoma	5.65e-05	0.000705	CbGpPWpGaD
Triamcinolone—CYP3A4—Biological oxidations—CYP1B1—melanoma	5.59e-05	0.000697	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—BCL2—melanoma	5.59e-05	0.000697	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—TNF—melanoma	5.56e-05	0.000693	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—MAPK1—melanoma	5.53e-05	0.00069	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—EGFR—melanoma	5.53e-05	0.00069	CbGpPWpGaD
Triamcinolone—CYP3A4—Metapathway biotransformation—CYP1B1—melanoma	5.52e-05	0.000688	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MDM2—melanoma	5.51e-05	0.000686	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLCB4—melanoma	5.5e-05	0.000686	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—ERBB2—melanoma	5.43e-05	0.000677	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—FASN—melanoma	5.4e-05	0.000673	CbGpPWpGaD
Triamcinolone—PTGS2—Selenium Micronutrient Network—IL6—melanoma	5.37e-05	0.00067	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NPPA—melanoma	5.36e-05	0.000668	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—LUM—melanoma	5.35e-05	0.000668	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—MAPK1—melanoma	5.27e-05	0.000657	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TNF—melanoma	5.27e-05	0.000657	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HPSE—melanoma	5.25e-05	0.000655	CbGpPWpGaD
Triamcinolone—NR3C1—Adipogenesis—IL6—melanoma	5.19e-05	0.000647	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC6A11—melanoma	5.17e-05	0.000645	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIP4K2A—melanoma	5.17e-05	0.000645	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CUBN—melanoma	5.15e-05	0.000643	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—MTAP—melanoma	5.03e-05	0.000627	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1B—melanoma	5.03e-05	0.000627	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PLA2G6—melanoma	4.99e-05	0.000622	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CSPG4—melanoma	4.98e-05	0.000621	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CASP3—melanoma	4.93e-05	0.000614	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—CYP1B1—melanoma	4.92e-05	0.000613	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RPS3—melanoma	4.9e-05	0.000611	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—SKI—melanoma	4.82e-05	0.000601	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CCND1—melanoma	4.8e-05	0.000598	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CTNNB1—melanoma	4.75e-05	0.000592	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—NOTCH1—melanoma	4.69e-05	0.000584	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—TP53—melanoma	4.64e-05	0.000579	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—CDKN1A—melanoma	4.64e-05	0.000578	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PTEN—melanoma	4.63e-05	0.000577	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—NFKB1—melanoma	4.61e-05	0.000574	CbGpPWpGaD
Triamcinolone—NR3C1—SIDS Susceptibility Pathways—IL6—melanoma	4.49e-05	0.000559	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PHGDH—melanoma	4.48e-05	0.000559	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—LUM—melanoma	4.48e-05	0.000559	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—VCAN—melanoma	4.48e-05	0.000559	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—PPARG—melanoma	4.42e-05	0.000551	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—HPSE—melanoma	4.4e-05	0.000548	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CUBN—melanoma	4.32e-05	0.000538	CbGpPWpGaD
Triamcinolone—PTGS2—Spinal Cord Injury—IL6—melanoma	4.25e-05	0.00053	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	4.24e-05	0.000529	CbGpPWpGaD
Triamcinolone—BCHE—Transmission across Chemical Synapses—HRAS—melanoma	4.23e-05	0.000527	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MMP1—melanoma	4.2e-05	0.000523	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—VEGFA—melanoma	4.18e-05	0.000521	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SDHD—melanoma	4.17e-05	0.00052	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CSPG4—melanoma	4.17e-05	0.00052	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—BSG—melanoma	4.17e-05	0.00052	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PPARG—melanoma	4.09e-05	0.00051	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GPAM—melanoma	4.04e-05	0.000503	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—MAPK1—melanoma	4.04e-05	0.000503	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HDAC6—melanoma	3.98e-05	0.000496	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK3—melanoma	3.95e-05	0.000493	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—HDAC2—melanoma	3.92e-05	0.000489	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MYC—melanoma	3.85e-05	0.00048	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP17A1—melanoma	3.78e-05	0.000471	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NPPA—melanoma	3.77e-05	0.00047	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—MAPK1—melanoma	3.76e-05	0.000469	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—EGFR—melanoma	3.76e-05	0.000469	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ACER3—melanoma	3.73e-05	0.000465	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	3.73e-05	0.000465	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—VCAN—melanoma	3.68e-05	0.000459	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—ALB—melanoma	3.68e-05	0.000459	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—WNT5A—melanoma	3.65e-05	0.000456	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TNF—melanoma	3.58e-05	0.000447	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GNA11—melanoma	3.57e-05	0.000445	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—KRAS—melanoma	3.55e-05	0.000443	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—FASN—melanoma	3.49e-05	0.000436	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—SLC5A5—melanoma	3.44e-05	0.000428	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PLA2G6—melanoma	3.43e-05	0.000428	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—UGT2B10—melanoma	3.41e-05	0.000425	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—IGF1—melanoma	3.36e-05	0.000418	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—GNAQ—melanoma	3.32e-05	0.000414	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CD44—melanoma	3.32e-05	0.000414	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—PIK3CA—melanoma	3.27e-05	0.000407	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	3.25e-05	0.000405	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—MMP2—melanoma	3.25e-05	0.000405	CbGpPWpGaD
Triamcinolone—BCHE—Neuronal System—HRAS—melanoma	3.24e-05	0.000404	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTGS2—melanoma	3.22e-05	0.000401	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—CYP1B1—melanoma	3.18e-05	0.000397	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HS3ST5—melanoma	3.17e-05	0.000395	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—TP53—melanoma	3.16e-05	0.000394	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—CDKN2B—melanoma	3.13e-05	0.000391	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—VCAN—melanoma	3.08e-05	0.000384	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—VDR—melanoma	3.05e-05	0.000381	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—GAB2—melanoma	2.93e-05	0.000366	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CG—melanoma	2.92e-05	0.000364	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FASN—melanoma	2.87e-05	0.000358	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PPARG—melanoma	2.82e-05	0.000351	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PRKCA—melanoma	2.82e-05	0.000351	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PTEN—melanoma	2.81e-05	0.00035	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—ERCC2—melanoma	2.79e-05	0.000348	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HDAC2—melanoma	2.76e-05	0.000344	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FOXO4—melanoma	2.76e-05	0.000344	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CXCR4—melanoma	2.76e-05	0.000344	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD44—melanoma	2.73e-05	0.00034	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CXCL8—melanoma	2.7e-05	0.000336	CbGpPWpGaD
Triamcinolone—PTGS2—Integrated Pancreatic Cancer Pathway—AKT1—melanoma	2.67e-05	0.000333	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ABCB1—melanoma	2.62e-05	0.000327	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP17A1—melanoma	2.6e-05	0.000324	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CD—melanoma	2.57e-05	0.00032	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—ALB—melanoma	2.53e-05	0.000316	CbGpPWpGaD
Triamcinolone—NR3C1—Generic Transcription Pathway—MYC—melanoma	2.52e-05	0.000314	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT3—melanoma	2.52e-05	0.000314	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of proteins—CTNNB1—melanoma	2.49e-05	0.00031	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GNA11—melanoma	2.46e-05	0.000306	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PRKCA—melanoma	2.41e-05	0.000301	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—FASN—melanoma	2.4e-05	0.0003	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLCB4—melanoma	2.4e-05	0.0003	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ERCC2—melanoma	2.39e-05	0.000298	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—SLC5A5—melanoma	2.37e-05	0.000295	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CD44—melanoma	2.28e-05	0.000285	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—GNAQ—melanoma	2.28e-05	0.000285	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC6A11—melanoma	2.26e-05	0.000282	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIP4K2A—melanoma	2.26e-05	0.000282	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—NOTCH1—melanoma	2.26e-05	0.000281	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CB—melanoma	2.24e-05	0.000279	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERBB4—melanoma	2.22e-05	0.000277	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN2B—melanoma	2.2e-05	0.000275	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—MTAP—melanoma	2.2e-05	0.000274	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—CYP1B1—melanoma	2.19e-05	0.000273	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD86—melanoma	2.13e-05	0.000266	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—PPARG—melanoma	2.13e-05	0.000265	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF1—melanoma	2.07e-05	0.000258	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PDGFRA—melanoma	2e-05	0.00025	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PRKCA—melanoma	1.98e-05	0.000247	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.98e-05	0.000247	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERCC2—melanoma	1.97e-05	0.000245	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PHGDH—melanoma	1.96e-05	0.000244	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—LUM—melanoma	1.96e-05	0.000244	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAP2K2—melanoma	1.94e-05	0.000242	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PTEN—melanoma	1.93e-05	0.000241	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—HPSE—melanoma	1.92e-05	0.000239	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CG—melanoma	1.89e-05	0.000235	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CUBN—melanoma	1.89e-05	0.000235	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HLA-A—melanoma	1.84e-05	0.00023	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—TERT—melanoma	1.84e-05	0.00023	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—RAC1—melanoma	1.84e-05	0.000229	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PPARG—melanoma	1.82e-05	0.000227	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SDHD—melanoma	1.82e-05	0.000227	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—BSG—melanoma	1.82e-05	0.000227	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CSPG4—melanoma	1.82e-05	0.000227	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ABCB1—melanoma	1.8e-05	0.000225	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GPAM—melanoma	1.76e-05	0.00022	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HIF1A—melanoma	1.76e-05	0.00022	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CD—melanoma	1.66e-05	0.000207	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PRKCA—melanoma	1.66e-05	0.000207	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ERCC2—melanoma	1.65e-05	0.000205	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—ALB—melanoma	1.64e-05	0.000204	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOS2—melanoma	1.6e-05	0.0002	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NOTCH1—melanoma	1.59e-05	0.000198	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD80—melanoma	1.56e-05	0.000194	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KIT—melanoma	1.55e-05	0.000194	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—APC—melanoma	1.55e-05	0.000194	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGF—melanoma	1.53e-05	0.000191	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PLA2G6—melanoma	1.5e-05	0.000187	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—BRAF—melanoma	1.46e-05	0.000182	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CB—melanoma	1.45e-05	0.00018	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTGS2—melanoma	1.43e-05	0.000179	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAP2K1—melanoma	1.37e-05	0.000171	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CD—melanoma	1.36e-05	0.00017	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism of lipids and lipoproteins—PIK3CA—melanoma	1.36e-05	0.00017	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—VCAN—melanoma	1.35e-05	0.000168	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—FGF2—melanoma	1.31e-05	0.000163	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CG—melanoma	1.3e-05	0.000162	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PPARG—melanoma	1.25e-05	0.000156	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PTEN—melanoma	1.25e-05	0.000156	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MAPK3—melanoma	1.25e-05	0.000156	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MDM2—melanoma	1.22e-05	0.000152	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—MYC—melanoma	1.21e-05	0.000151	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—ERBB2—melanoma	1.21e-05	0.00015	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CB—melanoma	1.19e-05	0.000148	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CD4—melanoma	1.19e-05	0.000148	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CD—melanoma	1.14e-05	0.000142	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP17A1—melanoma	1.14e-05	0.000142	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—ALB—melanoma	1.13e-05	0.000141	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1B—melanoma	1.12e-05	0.000139	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GNA11—melanoma	1.07e-05	0.000134	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CTNNB1—melanoma	1.05e-05	0.000131	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—FASN—melanoma	1.05e-05	0.000131	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—SLC5A5—melanoma	1.03e-05	0.000129	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—CDKN1A—melanoma	1.03e-05	0.000128	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PTEN—melanoma	1.03e-05	0.000128	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—GNAQ—melanoma	9.98e-06	0.000124	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CD44—melanoma	9.98e-06	0.000124	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CB—melanoma	9.96e-06	0.000124	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—CYP1B1—melanoma	9.56e-06	0.000119	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—STAT3—melanoma	9.19e-06	0.000115	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—NRAS—melanoma	9.17e-06	0.000114	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—PIK3CA—melanoma	8.82e-06	0.00011	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAPK3—melanoma	8.78e-06	0.000109	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PTEN—melanoma	8.61e-06	0.000107	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MYC—melanoma	8.54e-06	0.000106	CbGpPWpGaD
Triamcinolone—NR3C1—Gene Expression—AKT1—melanoma	8.42e-06	0.000105	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—MAPK1—melanoma	8.36e-06	0.000104	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—EGFR—melanoma	8.35e-06	0.000104	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—KRAS—melanoma	7.89e-06	9.84e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ABCB1—melanoma	7.88e-06	9.82e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—PIK3CA—melanoma	7.25e-06	9.04e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PRKCA—melanoma	7.25e-06	9.04e-05	CbGpPWpGaD
Triamcinolone—BCHE—Metabolism—AKT1—melanoma	7.21e-06	8.99e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ERCC2—melanoma	7.19e-06	8.96e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—HRAS—melanoma	6.71e-06	8.36e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—IL6—melanoma	6.42e-06	8.01e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—PIK3CA—melanoma	6.07e-06	7.57e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Disease—AKT1—melanoma	5.92e-06	7.39e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CG—melanoma	5.68e-06	7.08e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PPARG—melanoma	5.48e-06	6.83e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CD—melanoma	4.99e-06	6.22e-05	CbGpPWpGaD
Triamcinolone—PTGS2—Metabolism—AKT1—melanoma	4.96e-06	6.19e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—ALB—melanoma	4.93e-06	6.14e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CB—melanoma	4.35e-06	5.42e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTGS2—melanoma	4.31e-06	5.37e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PTEN—melanoma	3.76e-06	4.69e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—PIK3CA—melanoma	2.65e-06	3.31e-05	CbGpPWpGaD
Triamcinolone—CYP3A4—Metabolism—AKT1—melanoma	2.17e-06	2.7e-05	CbGpPWpGaD
